Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Diabetes Care

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 6376034
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Potentiation of Insulin Action by a Sulfonylurea in Primary Cultures of Hepatocytes from Normal and Diabetic Rats

  1983cited by this paper
• Insulin increases the maximum velocity for glucose uptake without altering the Michaelis constant in man. Evidence that insulin increases glucose uptake merely by providing additional transport sites.

  1982cited by this paper
• Hepatic and peripheral insulin resistance: A common feature of Type 2 (non-insulin-dependent) and Type 1 (insulin-dependent) diabetes mellitus

  1982cited by this paper
• The Effect of Chronic Sulfonylurea Therapy on Hepatic Glucose Production in Non-insulin-dependent Diabetes

  1982cited by this paper
• Effect of Sulfonylurea Treatment on In Vivo Insulin Secretion and Action in Patients With Non-insulin-dependent Diabetes Mellitus

  1982cited by this paper
• Comparison of the in vitro effect of biguanides and sulfonylureas on insulin binding of its receptors in target cells.

  1982cited by this paper
• In vitro effects of a sulfonylurea on insulin action in adipocytes. Potentiation of insulin-stimulated hexose transport.

  1981cited by this paper
• Mechanism and Significance of Insulin Resistance in Non-insulin-dependent Diabetes Mellitus

  1981cited by this paper
• Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus.

  1981cited by this paper
• Selective potentiation of insulin-mediated glucose disposal in normal dogs by the sulfonylurea glipizide.

  1981cited by this paper
• Dose-response characteristics for effects of insulin on production and utilization of glucose in man.

  1981cited by this paper
• Insulin binding to human adipocytes during late pregnancy in healthy, obese and diabetic state.

  1980cited by this paper
• Direct in vitro effect of a sulfonylurea to increase human fibroblast insulin receptors.

  1980cited by this paper
• In vitro metabolic effects of gliclazide and glibenclamide in the rat

  1980cited by this paper
• Erythrocyte Insulin Receptors in Non-insulin-dependent Diabetes Mellitus

  1980cited by this paper
• Sulfonylurea treatment of insulin-independent diabetes mellitus.

  1980cited by this paper
• Increased insulin sensitivity and cellular insulin binding in obese diabetics following treatment with glibenclamide.

  1979cited by this paper
• Erythrocytes: a new cell type for the evaluation of insulin receptor defects in diabetic humans.

  1979cited by this paper
• Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange.

  1978cited by this paper
• Characteristics of Human Erythrocyte Insulin Receptors

  1978cited by this paper
• The Pathogenic Role of an Insulin-receptor Defect in Diabetes Mellitus of the Obese

  1978cited by this paper
• Potentiation of the Hepatic Action of Insulin by Chlorpropamide

  1977cited by this paper
• Integrated control of hepatic glucose metabolism.

  1977cited by this paper
• Hepatic effects of oral hypoglycemic drugs.

  1977cited by this paper
• The Effect of Chronic Oral Antidiabetic Therapy on Insulin and Glucagon Responses to a Meal

  1977cited by this paper
• Insulin Binding in Diabetes: Relationships with Plasma Insulin Levels and Insulin Sensitivity

  1977cited by this paper
• Effects of sulfonylurea therapy on insulin binding to mononuclear leukocytes of diabetic patients.

  1976cited by this paper
• Nonketotic diabetes mellitus: insulin deficiency or insulin resistance?

  1976cited by this paper
• Locating the Site(s) of Insulin Resistance in Patients with Nonketotic Diabetes Mellitus

  1976cited by this paper
• A model of the kinetics of insulin in man.

  1974cited by this paper
• An Insulin Dependent Effect of Chronic Tolbutamide Administration on the Skeletal Muscle Carbohydrate Transport System

  1969cited by this paper
• A one-stage procedure for isolation of granulocytes and lymphocytes from human blood. General sedimentation properties of white blood cells in a 1g gravity field.

  1968cited by this paper
• The pattern of rsponse of plasma insulin and glucose to meals and fasting during chlorpropamide therapy.

  1968cited by this paper
• Effect of Chlorpropamide on Serum Glucose and Immunoreactive Insulin Concentrations in Patients with Maturity-onset Diabetes Mellitus

  1967cited by this paper
• The effects of long-term acetohexamide treatment on pancreatic islet cell function in maturity-onset diabetes.

  1966cited by this paper
• Coated charcoal immunoassay of insulin.

  1965cited by this paper
• POTENTIATION OF INSULIN ACTION ON THE LIVER BY TOLBUTAMIDE.

  1964cited by this paper
• ON THE HORMONAL REGULATION OF CARBOHYDRATE METABOLISM; STUDIES WITH C14 GLUCOSE.

  1963cited by this paper
• Compounds administered orally in the treatment of diabetes mellitus.

  1960cited by this paper
• LONG‐TERM STUDIES OF THE SULFONYLUREAS IN TOTALLY DEPANCREATIZED DOGS

  1957cited by this paper
• THE HYPOGLYCEMIC SULFONAMIDES: HISTORY AND DEVELOPMENT OF THE PROBLEM FROM 1942 TO 1955

  1957cited by this paper
• ACTION OF THE HYPOGLYCEMIC SULFONYL COMPOUNDS IN HYPOPHYSECTOMIZED, ADRENALECTOMIZED, AND DEPANCREATIZED ANIMALS

  1957cited by this paper

• Role of antidiabetic agents in type 2 diabetes patients with chronic kidney disease

  2023cites this paper
• Nephroprotective Properties of Antidiabetic Drugs

  2023cites this paper
• Berberine is an insulin secretagogue targeting the KCNH6 potassium channel

  2021cites this paper
• Mechanisms and characteristics of sulfonylureas and glinides.

  2019cites this paper
• Assessment on antioxidant and in vitro antidiabetes activities of different fractions of Citrus hystrix peel.

  2018cites this paper
• Investigation of Antihyperglycaemic Activity of Banana (Musa sp. Var. Nanjangud rasa bale) Flower in Normal and Diabetic Rats

  2017cites this paper
• Sulfonylureas: A New Look at Old Therapy

  2014cites this paper
• Sulphonylurea Antidiabetic Drugs

  2012cites this paper
• α-Glucosidase and α-Amylase Inhibitory Activity of Senna surattensis

  2012cites this paper
• Factors for development of secondary failure to sulfonylurea drugs in non-insulin-dependent diabetes mellitus

  2007cites this paper
• Quinolizidine alkaloids isolated from Lupinus species enhance insulin secretion.

  2004cites this paper
• Plasma glucose lowering effect of spartein sulphate infusion in non-insulin dependent (Type 2) diabetic subjects

  2004cites this paper
• Non Insulin-Dependent Diabetes Mellitus (Type 2) Secondary Failure. Metformin-Glibenclamide Treatment

  2001cites this paper
• Oral hypoglycemic agents: insulin secretagogues, alpha-glucosidase inhibitors and insulin sensitizers.

  2001cites this paper
• Pathophysiology and pharmacological treatment of insulin resistance.

  2000cites this paper
• The Use of Sulphonylureas in the Elderly

  1999cites this paper
• Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism.

  1999cites this paper
• Effect of adding a sulfonylurea in patients with non-insulin-dependent diabetes mellitus previously well controlled with insulin.

  1997cites this paper
• Photooxidation of Troglitazone, a New Antidiabetic Drug *

  1996cites this paper
• Role of Sulfonylureas in Non-Insulin-Dependent Diabetes Mellitus: Part I - “The pros”

  1996cites this paper
• Response of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide to glucose ingestion in non-insulin dependent diabetes mellitus

  1995cites this paper
• Sulfonylurea therapy improves glucose disposal without changing skeletal muscle GLUT4 levels in noninsulin-dependent diabetes mellitus subjects: a longitudinal study.

  1995cites this paper
• Prevention of Complications in Non-Insulin-Dependent Diabetes Mellitus (NIDDM)

  1995cites this paper
• Effects of glipizide on glucose metabolism and muscle content of the insulin-regulatable glucose transporter (GLUT 4) and glycogen synthase activity during hyperglycaemia in type 2 diabetic patients

  1994cites this paper
• Stimulation of glucose utilization in 3T3 adipocytes and rat diaphragm in vitro by the sulphonylureas, glimepiride and glibenclamide, is correlated with modulations of the cAMP regulatory cascade.

  1994cites this paper
• The sulphonylurea drug, glimepiride, stimulates release of glycosylphosphatidylinositol-anchored plasma-membrane proteins from 3T3 adipocytes.

  1993cites this paper
• Effects of Chronic Glipizide Treatment on the NIDD Heart

  1993cites this paper
• Increased muscle glucose uptake in response to chronic glyburide treatment is not related to changes in glucose transporter (GLUT4) protein.

  1993cites this paper
• The Effect of Glyburide on β-Cell Sensitivity to Glucose-Dependent Insulinotropic Polypeptide

  1993cites this paper
• The diabetogenes concept of NIDDM.

  1993cites this paper
• Hormonal responses and future treatment of non‐insulin‐dependent diabetes mellitus (NIDDM) *

  1993cites this paper
• Pathogenesis of NIDDM: A Balanced Overview

  1992cites this paper
• A high-monounsaturated-fat/low-carbohydrate diet improves peripheral insulin sensitivity in non-insulin-dependent diabetic patients.

  1992cites this paper
• Insulin plus a sulfonylurea agent for treating type 2 diabetes.

  1991cites this paper
• Effects of sulfonylureas on adipocyte and skeletal muscle insulin action in patients with non-insulin-dependent diabetes mellitus.

  1991cites this paper
• The Management of Diabetes Mellitus in Older Individuals

  1991cites this paper
• The Effect of Sulphonylurea Therapy on Skeletal Muscle Glycogen Synthase Activity and Insulin Secretion in Newly Presenting Type 2 (Non‐insulin‐dependent) Diabetic Patients

  1991cites this paper
• Dyslipidemia in type II Diabetes: Implications for Therapeutic Intervention

  1991cites this paper
• [Mode of action of hypoglycemic sulfanilamides].

  1991cites this paper
• Glyburide-Stimulated Glucose Transport in Cultured Muscle Cells via Protein Kinase C–Mediated Pathway Requiring New Protein Synthesis

  1991cites this paper
• Adjunctive Use of Tolazamide in Newly-Diagnosed Diabetic Children

  1990cites this paper
• Combination of Insulin with Glipizide Increases Peripheral Glucose Disposal in Secondary Failure Type 2 Diabetic Patients

  1990cites this paper
• Effects of Intensive Dietary Treatment on Insulin‐stimulated Skeletal Muscle Glycogen Synthase Activation and Insulin Secretion in Newly Presenting Type 2 Diabetic Patients

  1990cites this paper
• Adjunctive use of tolazamide in newly-diagnosed diabetic children.

  1990cites this paper
• Glucose Toxicity

  1990cites this paper
• Skeletal muscle glycogen synthase activity in subjects with non-insulin-dependent diabetes mellitus after glyburide therapy.

  1990cites this paper
• In vitro studies on the action of CS-045, a new antidiabetic agent.

  1990cites this paper
• Distribution of In Vivo Insulin Action in Pima Indians as Mixture of Three Normal Distributions

  1989cites this paper
• Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.

  1989cites this paper
• The effects of long term gliclazide administration on insulin secretion and insulin sensitivity.

  1989cites this paper
• Postreceptor Regulation of Insulin Action in Primary Cultures of Rat Hepatocytes by Oral Hypoglycemic Agents: Effects of Linogliride and Chlorpropamide

  1989cites this paper
• Diet only or diet and sulfonylureas in mild type II diabetes (niddm)? Pathophysiologic and therapeutic implications

  1988cites this paper
• Mechanism of Action of Sulphonylureas with Special Reference to the Extrapancreatic Effect: An Overview

  1988cites this paper
• The effects of glibenclamide treatment on insulin secretion and on insulin binding to erythrocytes in type II diabetes mellitus.

  1988cites this paper
• Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus.

  1988cites this paper
• Identification and treatment of patients receiving 'abusive' insulin therapy.

  1988cites this paper
• Insulin treatment of non-insulin-dependent diabetes mellitus.

  1988cites this paper
• Effect of Short- and Long-Term Chlorpropamide Therapy on Oral Glucose Tolerance and Erythrocyte Insulin Receptors in Non-Obese Non-Insulin Dependent Diabetes Mellitus

  1987cites this paper
• Insulin Action in Obese Non-Insulin-Dependent Diabetics and in Their Isolated Adipocytes Before and After Weight Loss

  1987cites this paper
• Effect of glyburide on glycogen metabolism in cultured rat hepatocytes.

  1987cites this paper
• Glyburide Decreases Insulin Requirement, Increases (β-Cell Response to Mixed Meal, and Does Not Affect Insulin Sensitivity: Effects of Short- and Long-Term Combined Treatment in Secondary Failure to Sulfonylurea

  1987influential citation
• Moderate insulinopenia can cause insulin antagonism.

  1987cites this paper
• Hyperglycemia Decreases Glucose Uptake in Type I Diabetes

  1987cites this paper
• Selective Unresponsiveness of Pancreatic β-Cells to Acute Sulfonylurea Stimulation During Sulfonylurea Therapy in NIDDM

  1986cites this paper
• Chlorpropamide Raises Fructose-2,6-Bisphosphate Concentration and Inhibits Gluconeogenesis in Isolated Rat Hepatocytes

  1986cites this paper
• Pathogenesis of type 2 diabetes mellitus: an interpretation of current data.

  1986cites this paper
• Effects of NIDDM on Very-Low-Density Lipoprotein Triglyceride and Apolipoprotein B Metabolism: Studies Before and After Sulfonylurea Therapy

  1986cites this paper
• Effect of tolazamide on basal ketogenesis, glycogenesis, and gluconeogenesis in liver obtained from normal and diabetic rats.

  1986cites this paper
• Potentiation of glucose-stimulated insulin release by tolazamide and paradoxical absence of glucose facilitation (Staub effect) in non-insulin-dependent diabetes.

  1986cites this paper
• Sulfonylureas in the treatment of diabetes mellitus--1985.

  1985cites this paper
• Dual actions of sulfonylureas and glyburide. Receptor and post-receptor effects.

  1985cites this paper
• Use of Glucose Uptake and Glucose Clearance for the Evaluation of Insulin Action In Vivo

  1984cites this paper
• World Journal of Diabetes

  year unknowncites this paper